BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report
The main method of fighting against colon cancer is targeted treatment. BRAF inhibitors, which are accepted as standard treatment for V600E mutant malign melanomas, are the newest approach for targeted treatment of V600E mutant colorectal cancers. In this case report, we share our experience about t...
Saved in:
Main Authors: | Yasar Subutay Peker, Mehmet Fatih Can, Ismail Hakki Ozerhan, Gokhan Yagci, Nazif Zeybek, Kutan Kavakli, Sedat Gurkok, Alper Gozubuyuk, Onur Genc, Gokhan Erdem, Ahmet Ozet, Mustafa Gerek, Yusuf Peker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Surgery |
Online Access: | http://dx.doi.org/10.1155/2018/8782328 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapy
by: Vinay K. Pattalachinti, et al.
Published: (2025-02-01) -
BRAF V600E-Negative Hairy Cell Leukaemia
by: Stephen E. Langabeer, et al.
Published: (2013-01-01) -
Novel therapy: Combined BRAF and MEK inhibitors for locally advanced BRAF V600L–Positive mucosal melanoma in hypopharynx
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer
by: Richard J. Robbins, et al.
Published: (2020-01-01) -
In-depth characterization of miRNome in papillary thyroid cancer with BRAF V600E mutation
by: Azliana Mohamad Yusof, et al.
Published: (2020-03-01)